Analytical Data
-
Gene name
CTHRC1
- Application
-
Alternative Names
CTHRC1;Collagen triple helix repeat-containing Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96CG8
-
Expression Region
31-243aa
-
AA Sequence
SEIPKGKQKA QLRQREVVDL YNGMCLQGPA GVPGRDGSPG ANGIPGTPGI PGRDGFKGEK GECLRESFEE SWTPNYKQCS WSSLNYGIDL GKIAECTFTK MRSNSALRVL FSGSLRLKCR NACCQRWYFT FNGAECSGPL PIEAIIYLDQ GSPEMNSTIN IHRTSSVEGL CEGIGAGLVD VAIWVGTCSD YPKGDASTGW NSVSRIIIEE LPK
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTHRC1 (Collagen triple helix repeat containing 1) is a protein that has garnered significant attention in recent years due to its pivotal role in various biological processes, including tissue remodeling, wound healing, and tumor progression. Initially discovered as a gene upregulated during wound healing, CTHRC1 is involved in the regulation of collagen deposition and has been implicated in the modulation of cell migration and differentiation. Research indicates that CTHRC1 enhances the invasive properties of cancer cells, making it a potential biomarker for aggressive tumors and a target for novel therapeutic strategies. As a result, the recombinant expression and characterization of CTHRC1 protein have become critical for understanding its functional mechanisms and potential applications in regenerative medicine and cancer biology. By producing CTHRC1 in a recombinant system, researchers aim to investigate its interactions with other proteins, its role in the extracellular matrix, and its therapeutic implications, thereby enhancing our knowledge of its contribution to both physiological and pathological processes. Ultimately, the study of recombinant CTHRC1 protein holds promise for advancing treatments for fibrotic diseases and cancer interventions.
